Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Therapeutic strategies for well-differentiated papillary mesothelioma of the peritoneum.

Lee YK, Jun HJ, Nahm JH, Lim TS, Park JS, Ahn JB, Rha SY, Chung HC, Oh HE, Song JS, Yang WI, Kim HS.

Jpn J Clin Oncol. 2013 Oct;43(10):996-1003. doi: 10.1093/jjco/hyt117. Epub 2013 Aug 20.

PMID:
23964112
2.

Well-differentiated papillary mesothelioma of the female peritoneum: a clinicopathologic study of 26 cases.

Malpica A, Sant'Ambrogio S, Deavers MT, Silva EG.

Am J Surg Pathol. 2012 Jan;36(1):117-27. doi: 10.1097/PAS.0b013e3182354a79.

PMID:
22024662
3.

Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).

Baratti D, Kusamura S, Nonaka D, Oliva GD, Laterza B, Deraco M.

Ann Surg Oncol. 2007 Oct;14(10):2790-7. Epub 2007 Jul 28.

PMID:
17661150
4.

Treatment of diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery and HIPEC.

Robella M, Vaira M, Mellano A, Marsanic P, Cinquegrana A, Borsano A, Barbera M, Caneparo A, Siatis D, Sottile A, De Simone M.

Minerva Chir. 2014 Feb;69(1):9-15.

PMID:
24675242
5.

The efficacy of the frontline platinum-based combination chemotherapy in malignant peritoneal mesothelioma.

Kim ST, Park JY, Lee J, Park JO, Park YS, Lim HY, Kang WK, Park SH.

Jpn J Clin Oncol. 2010 Nov;40(11):1031-6. doi: 10.1093/jjco/hyq083. Epub 2010 Jun 9.

PMID:
20534685
6.

Malignant pleural and peritoneal mesothelioma: incidental diagnosis and excellent treatment results.

Miliauskas S, Zemaitis M, Pranys D.

J Thorac Oncol. 2009 Mar;4(3):435-6. doi: 10.1097/JTO.0b013e3181989551. No abstract available.

7.

Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program.

Jänne PA, Wozniak AJ, Belani CP, Keohan ML, Ross HJ, Polikoff JA, Mintzer DM, Taylor L, Ashland J, Ye Z, Monberg MJ, Obasaju CK.

Clin Lung Cancer. 2005 Jul;7(1):40-6.

PMID:
16098243
8.

Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion.

Deraco M, Casali P, Inglese MG, Baratti D, Pennacchioli E, Bertulli R, Kusamura S.

J Surg Oncol. 2003 Jul;83(3):147-53.

PMID:
12827682
9.

Complete pathological response to neoadjuvant pemetrexed/cisplatin in combination with regional hyperthermia in a patient with sarcomatoid peritoneal mesothelioma.

Kruger S, Angele MK, Reu S, Sotlar K, Graser A, Haas M, Albertsmeier M, Stemmler HJ, Heinemann V, Lindner LH, Boeck S.

Anticancer Drugs. 2014 Aug;25(7):854-6. doi: 10.1097/CAD.0000000000000106.

PMID:
24637577
10.

Malignant peritoneal mesothelioma.

Bani-Hani KE, Gharaibeh KA.

J Surg Oncol. 2005 Jul 1;91(1):17-25.

PMID:
15999348
11.

Well-differentiated papillary mesothelioma.

Butnor KJ, Sporn TA, Hammar SP, Roggli VL.

Am J Surg Pathol. 2001 Oct;25(10):1304-9.

PMID:
11688466
12.

Deciduoid pleural mesothelioma in an adolescent.

Arango-Tomás E, Algar-Algar FJ, Salvatierra Velázquez A.

Arch Bronconeumol. 2013 May;49(5):218-9. doi: 10.1016/j.arbres.2012.10.005. Epub 2012 Dec 20. English, Spanish. No abstract available.

13.

Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

Baratti D, Vaira M, Kusamura S, D'Amico S, Balestra MR, Cioppa T, Mingrone E, De Simone M, Deraco M.

Eur J Surg Oncol. 2010 Nov;36(11):1047-53. doi: 10.1016/j.ejso.2010.08.130. Epub 2010 Sep 15.

PMID:
20832234
14.

[A difficult to treat case of malignant peritoneal mesothelioma with peritoneal metastasis].

Ojima T, Takai Y, Yamazaki K, Kamata T, Kanno M.

Gan To Kagaku Ryoho. 2013 Nov;40(12):2463-5. Japanese.

PMID:
24394145
15.

Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma.

Opitz I, Kestenholz P, Lardinois D, Müller M, Rousson V, Schneiter D, Stahel R, Weder W.

Eur J Cardiothorac Surg. 2006 Apr;29(4):579-84. Epub 2006 Feb 21.

PMID:
16495068
16.

[Malignant peritoneal mesothelioma tumours. Evolution, treatment, prognosis].

Scripcariu V, Dajbog E, Radu I, Ferariu D, Pricop A, Grigoraş M, Dragomir C.

Rev Med Chir Soc Med Nat Iasi. 2007 Jul-Sep;111(3):673-7. Romanian.

PMID:
18293699
17.

[A case of malignant peritoneal mesothelioma with the epithelioid histological type, successfully treated with pemetrexed plus cisplatin].

Kobayashi M, Moriwaki T, Ochi D, Saito R, Kobayashi K, Sugaya A, Akutsu D, Hamano Y, Imanishi M, Yamamoto Y, Yamada T, Nakano N, Sugano M, Hara K, Hyodo I.

Gan To Kagaku Ryoho. 2014 Mar;41(3):361-4. Japanese.

PMID:
24743284
18.

Combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for the treatment of malignant peritoneal mesothelioma.

Hesdorffer ME, Chabot JA, Keohan ML, Fountain K, Talbot S, Gabay M, Valentin C, Lee SM, Taub RN.

Am J Clin Oncol. 2008 Feb;31(1):49-54. doi: 10.1097/COC.0b013e3180684181.

PMID:
18376228
19.

Diagnosis and treatment of peritoneal mesothelioma: The Washington Cancer Institute experience.

Sugarbaker PH, Acherman YI, Gonzalez-Moreno S, Ortega-Perez G, Stuart OA, Marchettini P, Yoo D.

Semin Oncol. 2002 Feb;29(1):51-61.

PMID:
11836669
20.

Pemetrexed combined with platinum-based chemotherapy for advanced malignant peritoneal mesothelioma: retrospective analysis of six cases.

Nakano M, Kusaba H, Makiyama A, Ariyama H, Arita S, Oda H, Esaki T, Takayoshi K, Uchino K, Tamura S, Kumagai H, Iwama E, Shirakawa T, Mitsugi K, Takaishi S, Akashi K, Baba E.

Anticancer Res. 2014 Jan;34(1):215-20.

PMID:
24403465

Supplemental Content

Support Center